Related Experiment Video
Updated: Aug 8, 2026
06:51
Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Extended hormone replacement: who should get it, and for how long?
1Department of Family and Preventive Medicine, University of California, San Diego, La Jolla.
Geriatrics
|December 1, 1994
Summary
Hormone replacement therapy (HRT) may protect postmenopausal women from cardiovascular disease and osteoporosis. However, its effects on fracture risk and the potential association with breast cancer require careful consideration for older women.
Area of Science:
- Endocrinology
- Gerontology
- Cardiovascular Medicine
Background:
- Menopause leads to increased risk of chronic diseases like cardiovascular disease and osteoporosis.
- Hormone replacement therapy (HRT) is a potential intervention for mitigating these age-related health concerns.
- The optimal timing and long-term effects of HRT require further investigation.
Purpose of the Study:
- To evaluate the protective effects of HRT against cardiovascular disease and osteoporosis in postmenopausal women.
- To assess the impact of HRT initiation timing on fracture incidence.
- To address concerns regarding the association between HRT and breast cancer risk.
Main Methods:
- Review of existing data on HRT efficacy for cardiovascular disease and osteoporosis prevention.
- Analysis of studies examining HRT's effect on bone loss and fracture incidence in women at different stages post-menopause.
- Examination of literature concerning HRT and breast cancer risk.
Main Results:
- HRT may offer cardiovascular protection, potentially greater in women with higher risk factors.
- HRT might mitigate bone loss, but its effect on fracture incidence when initiated later in menopause is inconclusive.
- The relationship between HRT and breast cancer remains a significant concern.
Conclusions:
- HRT presents potential benefits for managing menopausal symptoms and chronic disease risk.
- Careful patient selection and counseling are crucial, especially regarding potential side effects and breast cancer risk.
- Further research is needed to clarify HRT's role in fracture prevention and long-term safety profiles.
Related Concept Videos
01:22Hormonal Regulation of the Menstrual Cycle
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
01:30Hormonal Control of the Ovarian Cycle
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:30Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...